Zobrazeno 1 - 10
of 57
pro vyhledávání: '"Somatostatin Receptor Agonist"'
Publikováno v:
Expert Rev Gastroenterol Hepatol
INTRODUCTION: (177)Lutetium-[DOTA°,Tyr(3)]octreotate ((177)Lu-DOTATATE) is a type of peptide receptor radionuclide therapy that garnered FDA approval in January 2018 for the treatment of somatostatin receptor-positive gastroenteropancreatic (GEP) ne
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a341181f9d2eec300d77718f2f49bb42
https://doi.org/10.1080/17474124.2019.1685381
https://doi.org/10.1080/17474124.2019.1685381
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
John Newell-Price, Alan Kelsall
Steroidogenesis inhibitors such as ketoconazole and metyrapone remain the mainstay in the medical management of Cushing's disease. Pituitary-directed therapies, including dopamine receptor antagonists and more recently somatostatin receptor agonists,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f824977b9832049e8be7101a29bfa80f
https://doi.org/10.1016/b978-0-12-819949-7.00046-9
https://doi.org/10.1016/b978-0-12-819949-7.00046-9
Autor:
Luca Dellamano, Giuseppe Lamberti, Renato Dellamano, Oscar Leeuwenkamp, Riccardo Laudicella, Sergio Baldari, Francesca Spada, Davide Campana
Purpose To assess and compare clinical outcomes and costs, to the Italian healthcare system, of three therapeutic options approved in the management of adult patients with gastro-enteropancreatic neuroendocrine tumours (GEP-NETs). Methods We compared
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::183d28a6303d41f01cf0e2be39642d60
https://hdl.handle.net/11585/904582
https://hdl.handle.net/11585/904582
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Tae Nakano-Tateno, Kheng Joe Lau, Justin Wang, Cailin McMahon, Yasuhiko Kawakami, Toru Tateno, Takako Araki
Publikováno v:
Frontiers in Endocrinology
Frontiers in Endocrinology, Vol 12 (2021)
Frontiers in Endocrinology, Vol 12 (2021)
Up to 35% of aggressive pituitary tumors recur and significantly affect mortality and quality of life. Management can be challenging and often requires multimodal treatment. Current treatment options, including surgery, conventional medical therapies
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::29fd2ffd7c514d9652d3b12ec44cbd52
https://pubmed.ncbi.nlm.nih.gov/33841328
https://pubmed.ncbi.nlm.nih.gov/33841328
Autor:
Terry Hyslop, Aileen Deng, Jean H. Hoffman-Censits, Serge Jabbour, Jianqing Lin, William Kevin Kelly, Deborah Kilpatrick, Geoffrey Gibney, Brooke Miller
Publikováno v:
Cancer Treatment Communications. 4:192-195
New areas of research continue to examine the role of non-androgen receptor pathways in prostate cancer treatment. The phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin (mTOR) pathway may be a target for prostate cancer therapy. Somatos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4a627b19c7e1b8ecd3e28616077d65b3
https://doi.org/10.1016/j.ctrc.2015.11.003
https://doi.org/10.1016/j.ctrc.2015.11.003
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Anatoliy I. Masyuk, Pui-Yuen Lee, Maria J. Lorenzo Pisarello, Tatyana V. Masyuk, Sergio A. Gradilone, Jingyi Francess Ding, Nicholas F. LaRusso
Publikováno v:
The American journal of pathology. 188(4)
Hepatic cystogenesis in polycystic liver disease (PLD) is associated with abnormalities in multiple cellular processes, including elevated cAMP and overexpression of histone deacetylase 6 (HDAC6). Disease progression in polycystic kidney (PCK) rats (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6681dee64e628a891248863c1b16d8f
https://pubmed.ncbi.nlm.nih.gov/29366679
https://pubmed.ncbi.nlm.nih.gov/29366679
Autor:
Nicholas A. Tritos, Maya Barake
Publikováno v:
International Journal of Endocrine Oncology. 1:163-171
Thyrotropin (TSH)-secreting pituitary adenomas are uncommon pituitary neoplasms. They have been increasingly recognized with the advent of ultrasensitive TSH assays and advanced pituitary imaging. Clinically, patients may often present with signs and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3ac10f8792b027edb4d6b2a2cd186672
https://doi.org/10.2217/ije.14.15
https://doi.org/10.2217/ije.14.15